News
-
-
-
PRESS RELEASE
Abivax Announces Launch of Public Offering
Abivax announces launch of $400 million public offering to fund therapeutics for chronic inflammatory diseases. Underwritten by Leerink Partners, Piper Sandler, Guggenheim Securities, with LifeSci Capital, BTIG, Van Lanschot Kempen as managers -
-
-
-
-
-
PRESS RELEASE
Inside Information / News release on accounts, results
-
REGULATED PRESS RELEASE
2025 First-half sales and results